The UK's most complete GLP-1 guide
Every Question Answered. Every Side Effect Explained.
- How GLP-1 medications work
- Mounjaro vs Wegovy compared
- Injection instructions
- Side effects & solutions
- What to eat on treatment
- FAQs answered
Free tracker included with every download this week
Mounjaro Face — UK Access and Cost Guide
"Mounjaro face" is a colloquial term used to describe changes in facial appearance some people experience when using tirzepatide (Mounjaro), a weekly weight loss injection. These changes can include loss of facial volume, skin laxity, or a hollowed appearance — typically resulting from gradual weight management rather than the medication itself. This guide explains what Mounjaro face is, how to access Mounjaro in the UK, what it costs, and the difference between NHS and private routes.
10,000+ calculations today · NHS-aligned thresholds · 100% free
Calculate Your BMI Instantly
Enter your height and weight below. Supports both imperial (stone & lbs) and metric (kg). Results include NHS category, healthy weight range, and ethnicity adjustments.
What Is BMI and Why Does It Matter?
Body Mass Index (BMI) is the most widely used screening tool for assessing whether your weight falls within a healthy range. Used by the NHS, GPs, and weight management services across the UK, BMI provides a quick snapshot of your weight relative to your height. The formula is simple: your weight in kilograms divided by your height in metres squared (kg/m²).
While BMI isn't a perfect measure — it doesn't account for muscle mass, bone density, or fat distribution — it remains the standard first step in identifying potential weight-related health risks including type 2 diabetes, cardiovascular disease, high blood pressure, and certain cancers.
The NHS also recommends adjusted thresholds for people of South Asian, Chinese, or Black African heritage — a BMI of 23 or above is classified as overweight, and 27.5 as obese. Our calculator includes this adjustment as a one-click toggle.
Mounjaro Facial Changes and Weight Loss Context
What causes Mounjaro face? The facial changes associated with "Mounjaro face" are not a direct side effect of tirzepatide itself, but rather a consequence of significant weight loss. As you lose weight — particularly when using a GLP-1 receptor agonist or dual GIP/GLP-1 receptor agonist like Mounjaro — your body loses fat from all areas, including the face. This can result in reduced cheek volume, more prominent cheekbones, hollowed cheeks, or a gaunt appearance.
- gradual weight management (over 0.75 kg per week) increases the likelihood of noticeable facial changes
- Individual genetics determine where your body loses fat first — some people lose facial volume quickly, others don't
- Loss of skin elasticity with gradual weight management can contribute to a looser appearance
- Facial changes are often reversible if weight stabilises or is regained
To manage facial changes, many people adopt a slower weight loss pace (0.5 kg per week), focus on protein intake to preserve muscle, use skincare and moisturising routines, and consider dermatological treatments like fillers once weight loss stabilises.
Clinically BackedWeight Loss
No appointments. No waiting rooms. Just care — from a UK-regulated online pharmacy.
How It Works
Three simple steps to understand your weight and take action.
Enter your height and weight in our free calculator. Get your BMI, NHS category, healthy weight range, and ethnicity-adjusted thresholds instantly.
If your BMI suggests you're overweight or obese, explore our GLP-1 calculators to project potential weight loss on Mounjaro or Wegovy.
Use our progress tracker to log your weight weekly, visualise your journey with charts, and stay motivated — all stored privately in your browser.
Free Weight Loss Tools & Guides
Everything you need to understand your weight, explore medication options, and track your progress — completely free.
How to Access Mounjaro in the UK — NHS vs Private
NHS route: Mounjaro is available through NHS tier 3 specialist weight management services. You must be referred by your GP to a specialist service in your region. NHS access is free at point of use but involves waiting lists — some regions have waits of 6–12 months or longer. Eligibility requires a BMI of 30 or above, or 27–29.9 with weight-related health conditions (adjusted thresholds apply for South Asian and other groups).
Private route: Mounjaro is available through UK-licensed online prescribers. You complete an online consultation with a registered prescriber who assesses your suitability. If approved, a prescription is issued and dispensed by a GPhC-registered pharmacy. Private access is faster (often within days) but costs approximately £150–£250 per month depending on dose. Try our free GLP-1 weight loss calculator to explore projected outcomes at different doses.
- Dual GIP/GLP-1 receptor agonist
- Up to 22.5% body weight loss (SURMOUNT-1)
- Weekly injection, dose escalation over 20+ weeks
- Available via private prescription in the UK
- Doses: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg
- GLP-1 receptor agonist
- Up to 15–17% body weight loss (STEP trials)
- Weekly injection, 5-step dose escalation
- NHS & private prescription available
- Doses: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg
Mounjaro vs Wegovy: Head-to-Head
A side-by-side comparison of the two most popular GLP-1 weight loss medications available in the UK.
| Feature | Mounjaro | Wegovy |
|---|---|---|
| Drug class | Dual GIP/GLP-1 agonist | GLP-1 agonist |
| Active ingredient | Tirzepatide | Semaglutide |
| Avg. weight loss | 15–22.5% | 12–17% |
| Key trial | SURMOUNT-1 (2022) | STEP 1 (2021) |
| Max dose | 15 mg weekly | 2.4 mg weekly |
| Escalation period | 20–32 weeks | 16–20 weeks |
| Administration | Weekly injection (pen) | Weekly injection (pen) |
| NHS availability | Private prescription only | NHS & private |
| Approx. private cost | £150–£250/month | £150–£300/month |
| Common side effects | Nausea, diarrhoea, constipation | Nausea, vomiting, diarrhoea |
Data sourced from SURMOUNT-1 and STEP 1 clinical trials. Costs are approximate and vary by provider. Always consult a prescriber.
Am I Eligible for Weight Loss Medication?
In the UK, eligibility for GLP-1 weight loss medications like Mounjaro and Wegovy is based on your BMI and overall health profile.
- BMI of 30 or above (obese)
- Age 18 or over
- No contraindicated conditions
- Committed to lifestyle changes
- BMI of 27 or above
- Plus type 2 diabetes
- Or high blood pressure
- Or obstructive sleep apnoea
Use our BMI calculator to check whether your BMI falls within the eligible range.
How We Built These Tools
Every calculator and guide on myweightcheck is built with accuracy and transparency in mind. Our BMI calculator uses the standard WHO formula with NHS-aligned category thresholds. Our GLP-1 projections are modelled on published clinical trial data from SURMOUNT and STEP studies.
All data stays on your device. We don't require sign-ups, and we don't store your health information on any server. Your progress tracker saves data locally in your browser using localStorage, so only you can see it.
We're based in the UK and our tools are designed specifically for UK users — supporting stone & lbs by default, referencing NHS guidelines, using NICE-approved medication data, and linking to GPhC-registered pharmacies.
Frequently Asked Questions
Common questions about BMI, weight loss medications, and our free UK tools.
Does Mounjaro directly cause facial changes?
No. Mounjaro (tirzepatide) does not directly cause facial changes. The appearance changes associated with "Mounjaro face" result from significant weight loss. As fat reduces throughout the body, facial volume decreases, which can create a gaunt or hollowed appearance. This is a consequence of weight loss, not a medication side effect.
Can I prevent Mounjaro face?
You cannot prevent facial volume loss entirely during weight loss, but you can minimise it. Lose weight gradually (0.5 kg per week rather than faster rates), maintain adequate protein intake to preserve muscle, stay hydrated, use good skincare, and consider treatments like dermal fillers once your weight stabilises. Our progress tracker can help you monitor a steady, sustainable pace.
How much does Mounjaro cost privately in the UK?
Private Mounjaro costs vary by dose and provider but typically range from £150–£250 per month. Starting doses (2.5 mg) are usually cheaper than maximum doses (15 mg). Each KwikPen contains four weekly doses. Some providers offer discounts for upfront payment or longer-term prescriptions. Always check the current pricing with your chosen prescriber.
How long is the NHS waiting list for Mounjaro?
NHS waiting times vary significantly by region and local ICB (integrated care board). Some areas have waits of 3–6 months, whilst others may be 12+ months. Contact your GP or local weight management service for specific timelines. Check your BMI using our free BMI calculator to confirm eligibility first.
What's the difference between getting Mounjaro on the NHS versus privately?
NHS: free, but slow (waiting lists), requires GP referral and specialist assessment. Private: faster (days), costs £150–£250/month, requires online consultation with a UK-licensed prescriber. Both require clinical assessment. Private access is available immediately without NHS referral; NHS access depends on regional availability and capacity.
Ready to take control of your weight loss journey?
Start with a free BMI check, explore your GLP-1 options, or begin tracking your progress today. No sign-up. No cost. Just results.